Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study

  1. Salgado, M.
  2. Reboredo, M.
  3. Mendez, J.C.
  4. Quintero, G.
  5. Pellón, M.L.
  6. Romero, C.
  7. Jorge, M.
  8. Montes, A.F.
  9. Valladares-Ayerbes, M.
  10. Ramos, M.
  11. Varela, S.
  12. Alonso, M.A.
Journal:
Anticancer Research

ISSN: 0250-7005

Year of publication: 2013

Volume: 33

Issue: 9

Pages: 4089-4096

Type: Article